Clin2
NCT04629547Possibly a fitRecruiting

Sleep study to help prevent Alzheimer’s disease

SleepAlzheimer Disease

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests whether treating sleep issues and measuring sleep can help lower the risk of Alzheimer’s disease before it starts. It focuses on older adults with no dementia signs yet.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
65 years and older
Study type
Interventional

Who can take part

  • Age 65 or older, and able to understand and sign consent
  • No signs of dementia right now (CDR rating of 0)
  • Willing to follow all study sleep and medical procedures
  • No history or symptoms strongly suggesting restless legs, narcolepsy, or other sleep-schedule disorders
  • No untreated or poorly treated sleep apnea (home test AHI 15+ or not using CPAP reliably)
  • Blood and other health limits must fit study safety rules

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06274528Recruiting· Phase 2
DORA and lemborexant in Alzheimer's biomarkers study

This study is testing whether a sleep medication called lemborexant can improve sleep and reduce Alzheimer's-related proteins in healthy older adults with no memory problems. It could help find new ways to delay or prevent Alzheimer's disease.

St Louis, Missouri
NCT04601038Recruiting· Phase 2
Testing a stress-blocking drug for early Alzheimer's risk

This study tests a new medication, CORT108297, that may help protect the brain from the harmful effects of stress in people at risk for Alzheimer's disease. It is looking for adults age 55 and older who either have mild memory problems or are healthy but have a family history, APOE4 gene, or memory concerns.

Baltimore, Maryland
NCT05924425Recruiting· Phase 4
Daridorexant for insomnia in early memory decline

This trial tests whether daridorexant can improve sleep in people who have mild cognitive impairment or early Alzheimer’s disease and struggle with insomnia. It may help by improving how long and how well you sleep, with monitoring of sleep patterns and memory-related measures.

Montpellier
NCT06619613Recruiting· Phase 1
Study of CM383 for early Alzheimer's disease

This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.

Hefei
NCT07222449Enrolling by invitation
Wearable devices and blood tests for sleep in Alzheimer's

This study uses wrist monitors and blood tests to understand sleep problems in people with Alzheimer's dementia. It aims to improve sleep management through digital therapy and personalized insights.

Beigang, Yunlin
NCT05649514Recruiting
Studying sleep problems in early Alzheimer’s risk patients

This study looks at sleep problems in people with mild Alzheimer’s disease and whether sleep measurements and questionnaires can help researchers understand early changes. You may be able to join if your diagnosis is mild and you can complete repeated sleep and thinking questionnaires with a family caregiver’s help.

Montpellier, Hérault

Hear when a new Sleep trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.